Moderator: Sarah Medrek, MD

Welcome
Oksana Shlobin, MD, Inova Fairfax Hospital, Fairfax, VA, USA

Program Panel Introduction
Sarah Medrek, MD, University of New Mexico, Albuquerque, NM, USA

(12) Results from the REPAIR Study: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH)
Anton Vonk Noordegraaf, Amsterdam University Medical Center, Amsterdam, Netherlands

(14) INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension
Nicholas S. Hill, MD, Tufts Medical Center, Boston, MA, USA

(15) The Relationship between Pulmonary Artery Pulse Pressure and Pulmonary Artery Wedge Pressure during Exercise in Health and in Patients with Suspected Pulmonary Hypertension
Robert F. Bentley, PhD, University of Toronto, Toronto, ON, Canada

(16) Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study
Raymond L. Benza, MD, FACC, The Ohio State University Wexner Medical Center, Columbus, OH, USA

(17) Patients with Methamphetamine-Associated Pulmonary Arterial Hypertension Have Less Favorable Hemodynamics Than Other Patients with Group 1 PAH
Elena Vasti, MD, MPH, Stanford University School of Medicine, Stanford, CA, USA

(18) Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
Jasjeet Khural, MD, Medical University of South Carolina, Charleston, SC, USA

Moderated Q & A
 

Continuing Education Information

Learning Objectives – at the conclusion of this session, attendees will be able to:

• Discuss the Effects of Macitentan on Right Ventricular (RV) Remodeling in Pulmonary Arterial Hypertension
• Discuss the final results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension
• Discuss the Relationship between Pulmonary Artery Pulse Pressure and Pulmonary Artery Wedge Pressure during Exercise in Health and in Patients with Suspected Pulmonary Hypertension
• Discuss Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study
• Discuss Patients with Methamphetamine-Associated Pulmonary Arterial Hypertension Have Less Favorable Hemodynamics Thank Other Patients with Group 1 PAH
• Discuss the Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
   

Target Audience – The target audience includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.

Activity Designed to Change – This activity is designed to change knowledge, competence and performance.

Learning Attributes   Patient Care and Medical Knowledge

Disclosures – Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.

Disclaimer – The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.

Documenting CME Credits – The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf..